Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Urogynecology (Phila) ; 30(3): 309-313, 2024 03 01.
Article in English | MEDLINE | ID: mdl-38484247

ABSTRACT

ABSTRACT: Concurrent cervical cancer with advanced pelvic organ prolapse is rare: there are no well-established treatment recommendations. It is hypothesized that chronic irritation, as with long-standing pelvic organ prolapse, may lead to dysplasia and human papillomavirus-independent carcinoma, which represents only 5% of cervical cancers. Two patients with complete uterine procidentia were referred to gynecologic oncology with cervical squamous cell carcinoma; both were clinically staged as International Federation of Gynaecology and Obstetrics IB3. Treatment planning was complicated by procidentia in both cases. Standard definitive treatment of locally advanced cervical cancer is radiation therapy and concurrent chemotherapy; however, the mobility and externalization of the target lesion raised concerns regarding anatomic reproducibility during radiation treatment. After multidisciplinary team discussion (gynecologic oncology, urogynecology, radiation oncology), surgical resection and co-management with gynecologic oncology and urogynecology were successfully performed for definitive management for both patients. Although rare, this case study demonstrates the importance of multidisciplinary coordination in these complex clinical scenarios.


Subject(s)
Carcinoma, Squamous Cell , Genital Neoplasms, Female , Pelvic Organ Prolapse , Uterine Cervical Neoplasms , Humans , Female , Uterine Cervical Neoplasms/complications , Cisplatin , Carcinoma, Squamous Cell/complications , Genital Neoplasms, Female/drug therapy , Reproducibility of Results , Pelvic Organ Prolapse/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...